Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
57.55
+0.40 (0.70%)
May 22, 2026, 1:32 PM EDT - Market open
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 |
|---|
| 1.70B | | | | | | | | | | | | | | | | | | | | | | | |
| 7.86% | | | | | | | | | | | | | | | | | | | | | | | |
| 3.50B | | | | | | | | | | | | | | | | | | | | | | | |
Cardiovascular Revenue Growth | 13.55% | | | | | | | | | | | | | | | | | | | | | | | |
| -1.00M | | | | | | | | | | | | | | | | | | | | | | | |
| 5.20B | | | | | | | | | | | | | | | | | | | | | | | |
| 11.58% | | | | | | | | | | | | | | | | | | | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 |
|---|
| 3.28B | | | | | | | | | | | | | | | | | | | | | | | |
| 10.95% | | | | | | | | | | | | | | | | | | | | | | | |
Europe, Middle East and Africa Revenue | 932.00M | | | | | | | | | | | | | | | | | | | | | | | |
Europe, Middle East and Africa Revenue Growth | 10.17% | | | | | | | | | | | | | | | | | | | | | | | |
| 803.00M | | | | | | | | | | | | | | | | | | | | | | | |
Asia-Pacific Revenue Growth | 14.55% | | | | | | | | | | | | | | | | | | | | | | | |
Latin America and Canada Revenue | 185.00M | | | | | | | | | | | | | | | | | | | | | | | |
Latin America and Canada Revenue Growth | 19.36% | | | | | | | | | | | | | | | | | | | | | | | |
| -1.00M | | | | | | | | | | | | | | | | | | | | | | | |
| 5.20B | | | | | | | | | | | | | | | | | | | | | | | |
| 11.58% | | | | | | | | | | | | | | | | | | | | | | | |
Key Performance Indicators
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 |
|---|
MedSurg Organic Revenue Growth | 5.70% | | | | | | | | | | | | | | | | | | | | | | | |
Cardiovascular Organic Revenue Growth | 11.20% | | | | | | | | | | | | | | | | | | | | | | | |
Total Organic Revenue Growth | 9.40% | | | | | | | | | | | | | | | | | | | | | | | |
Updated May 1, 2026. Data Source:
Fiscal.ai.
